BioMall
Brand Store/BDB Bioscience/BD HorizonTM BV650 Rat Anti-Mouse CD279 (PD-1)
B
GENERAL CATALOGUE

BD HorizonTM BV650 Rat Anti-Mouse CD279 (PD-1)

568616 · 0.1 mg

BDB Bioscience · Cat: 568616

₹200 – ₹300 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 568616
Category: reagents
Pack Size: 0.1 mg
Brand: BDB Bioscience

Description

Flow cytometric analysis of CD279 PD-1 expression on resting and activated viable Mouse splenic leucocytes. C57BL/6 Mouse splenocytes were either not activated Left Plot or activated Right Plot by culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 567114/567115 for 3 days 37C . The cells were harvested, washed and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . Cells were then stained with either BD Horizon BV650 Rat IgG2a, kappa Isotype Control Cat. No. 563236; dashed line histograms or BD Horizon BV650 Rat Anti-Mouse CD279 PD-1 antibody Cat. No. 568616/568617; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing the expression of CD279 PD-1 or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of CD279 PD-1 expression on resting and activated viable Mouse splenic leucocytes. C57BL/6 Mouse splenocytes were either not activated Left Plot or activated Right Plot by culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 567114/567115 for 3 days 37C . The cells were harvested, washed and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . Cells were then stained with either BD Horizon BV650 Rat IgG2a, kappa Isotype Control Cat. No. 563236; dashed line histograms or BD Horizon BV650 Rat Anti-Mouse CD279 PD-1 antibody Cat. No. 568616/568617; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing the expression of CD279 PD-1 or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of CD279 PD-1 expression on resting and activated viable Mouse splenic leucocytes. C57BL/6 Mouse splenocytes were either not activated Left Plot or activated Right Plot by culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 567114/567115 for 3 days 37C . The cells were harvested, washed and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . Cells were then stained with either BD Horizon BV650 Rat IgG2a, kappa Isotype Control Cat. No. 563236; dashed line histograms or BD Horizon BV650 Rat Anti-Mouse CD279 PD-1 antibody Cat. No. 568616/568617; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing the expression of CD279 PD-1 or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of CD279 PD-1 expression on resting and activated viable Mouse splenic leucocytes. C57BL/6 Mouse splenocytes were either not activated Left Plot or activated Right Plot by culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 567114/567115 for 3 days 37C . The cells were harvested, washed and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . Cells were then stained with either BD Horizon BV650 Rat IgG2a, kappa Isotype Control Cat. No. 563236; dashed line histograms or BD Horizon BV650 Rat Anti-Mouse CD279 PD-1 antibody Cat. No. 568616/568617; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing the expression of CD279 PD-1 or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of CD279 PD-1 expression on resting and activated viable Mouse splenic leucocytes. C57BL/6 Mouse splenocytes were either not activated Left Plot or activated Right Plot by culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 567114/567115 for 3 days 37C . The cells were harvested, washed and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . Cells were then stained with either BD Horizon BV650 Rat IgG2a, kappa Isotype Control Cat. No. 563236; dashed line histograms or BD Horizon BV650 Rat Anti-Mouse CD279 PD-1 antibody Cat. No. 568616/568617; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing the expression of CD279 PD-1 or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of CD279 PD-1 expression on resting and activated viable Mouse splenic leucocytes. C57BL/6 Mouse splenocytes were either not activated Left Plot or activated Right Plot by culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 567114/567115 for 3 days 37C . The cells were harvested, washed and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . Cells were then stained with either BD Horizon BV650 Rat IgG2a, kappa Isotype Control Cat. No. 563236; dashed line histograms or BD Horizon BV650 Rat Anti-Mouse CD279 PD-1 antibody Cat. No. 568616/568617; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing the expression of CD279 PD-1 or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience

B
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
B
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
B
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
B
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
B
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
B
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
B
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
B
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents